Earnhardt Lisa D 4
4 · ABBOTT LABORATORIES · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Earnhardt Lisa D
EVP AND GROUP PRESIDENT
Transactions
- Exercise/Conversion
Common shares without par value
2025-03-07$80.98/sh+200$16,196→ 72,128 total - Exercise/Conversion
Common shares without par value
2025-03-06$80.98/sh+91,167$7,382,704→ 163,095 total - Sale
Common shares without par value
2025-03-07$136.65/sh−200$27,329→ 71,928 total - Sale
Common shares without par value
2025-03-06$133.82/sh−91,167$12,199,968→ 71,928 total - Exercise/Conversion
Option (right to buy)
2025-03-07−200→ 0 totalExercise: $80.98From: 2022-06-10Exp: 2029-06-09→ Common shares (200 underlying) - Exercise/Conversion
Option (right to buy)
2025-03-06−91,167→ 200 totalExercise: $80.98From: 2022-06-10Exp: 2029-06-09→ Common shares (91,167 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.